The MetS as currently defined by the ATP III panel includes 5 components. The background for their inclusion in the syndrome, measurement of the factors, and the appropriate interventions are described in this review. The factors are highly interrelated, and the utility of this diagnostic entity is under critical evaluation as new and existing data are evaluated concerning the role of the syndrome in the development of cardiovascular and metabolic outcomes.
|Original language||English (US)|
|Number of pages||4|
|State||Published - Sep 30 2003|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)